An additional mechanism of AST and AST-LI is the downregulation of GSK-3B-induced P-tau and Aβ plaques that underlie the observed improvements in neurotransmitter balance, behavioral scores, synaptic function, and cognitive loss linked to AD. This evidence concerns the gene GSK3B and Alzheimer disease.